Skip to content
DeepViews

Alcon Inc. Ordinary Shares (ALC) — Analysis Summary

Alcon Inc. Ordinary Shares (ALC) has a market cap of $34.81B with year-over-year revenue growth of +4.9%. Net margin stands at 9.4%. The stock trades at a P/E ratio of 35.5.

Key Takeaways

  • Revenue changed +4.9% year-over-year
  • Net margin of 9.4%
  • P/E ratio of 35.5

Compared with its sector, ALC posted revenue growth of +4.9% and trades at a P/E of 35.5.

[XNYS]

Alcon Inc. Ordinary Shares (ALC)

$72.01

UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$34.81B
Enterprise Value
$33.28B
P/E Ratio
35.5
Div Yield
0.39%
EV/EBITDA
N/A
Company Profile
About
About Alcon Inc. Ordinary Shares

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Employees

25,942

Exchange

XNYS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
68
Narrow Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$22.04B
Total Debt$0.00M
Debt-to-Equity0.00
Cash & Equivalents$1527.00M

Cash Flow

Operating Cash Flow$2271.00M
Free Cash Flow$1728.00M
FCF Margin16.61%
P/FCF Ratio20.14
Source: Polygon.io · SEC EDGAR
Dividends
Dividends

Annual Dividend/Share

$0.28

Dividend Yield

0.39%

Annual
Last Ex-Date: 2026-05-06

Dividend History

2026-05-06
CD$0.2800
2025-05-14
CD$0.2800
2024-05-14
CD$0.2400
2023-05-10
CD$0.2100
Source: Polygon.io
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.